TrialPloS one2023

Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)-IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201.

Hiromasa Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.